[Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance]. [electronic resource]
Producer: 20040610Description: 295-302 p. digitalISSN:- 0015-5691
- Clinical Trials as Topic
- Humans
- Meningeal Arteries -- metabolism
- Migraine Disorders -- drug therapy
- Quality of Life
- Receptor, Serotonin, 5-HT1B -- physiology
- Receptor, Serotonin, 5-HT1D -- physiology
- Serotonin 5-HT1 Receptor Agonists
- Tablets
- Triazoles -- administration & dosage
- Trigeminal Nerve -- metabolism
- Tryptamines
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.